TATVA CHINTAN PHARMA CHEM
|
|
BOM : 543321     NSE : TATVA     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : NA |
Mar 22,2023 |
Price(EOD): ₹ 1,724.90
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Chemicals |
MCap: ₹ 3,829.28 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
TATVA CHINTAN PHARMA CHEM | -3.1% | -12.7% | -23.2% |
PIDILITE INDUSTRIES | 1.5% | 2.5% | -5.2% |
SOLAR INDUSTRIES (INDIA) | 1.7% | -3.8% | 45.2% |
GUJARAT FLUOROCHEMICALS | 2.2% | 3.5% | 2.7% |
DEEPAK NITRITE | -0.3% | -0.4% | -20.9% |
TATA CHEMICALS | 0.3% | -4.9% | 1.4% |
ATUL | 1.2% | -1.5% | -28.5% |
AARTI INDUSTRIES | -0.1% | -4.1% | -42.9% |
NAVIN FLUORINE INTERNATIONAL | 2.3% | -1.8% | 2.5% |
FUNDAMENTAL ANALYSIS OF TATVA CHINTAN PHARMA CHEM
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF TATVA CHINTAN PHARMA CHEM
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
83.04
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 46.04 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] 8.08
P/B Calculated based on Book Value of Rs 473.09 Cr
[Latest Year - Mar2022 - Consolidated Results ] 9.62
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 397.63 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
1608% 2165% -5% |
SHARE PRICE MOMENTUM OF TATVA CHINTAN PHARMA CHEM
TATVA CHINTAN PHARMA CHEM vs SENSEX
DEBT OF TATVA CHINTAN PHARMA CHEM
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.26 0.56 0.79 0.54 |
0.25 0.54 0.77 0.52 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF TATVA CHINTAN PHARMA CHEM
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF TATVA CHINTAN PHARMA CHEM
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
33.87% 60.27% 57.02% 63.43% |
15.23% -25.11% -44.15% -49.04% |
QtrlyTrend |
2 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
TATVA CHINTAN PHARMA CHEM related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE ALLCAP | 0.9% | -3.6% | -1.7% |
S&P BSE BASIC MATERIALS | 0.3% | -3.4% | -8.3% |
S&P BSE SMALL CAP | 0% | -3.1% | -1.9% |
S&P BSE MIDSMALLCAP | NA | -2.9% | -0.6% |
You may also like the below Video Courses
FAQ about TATVA CHINTAN PHARMA CHEM
Is TATVA CHINTAN PHARMA CHEM good for long term investment?
As on Mar 22,2023, the Fundamentals of TATVA CHINTAN PHARMA CHEM look Strong and hence it may be good for long term investment! See Financial Performance of TATVA CHINTAN PHARMA CHEM . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is TATVA CHINTAN PHARMA CHEM UnderValued or OverValued?
As on Mar 22,2023, TATVA CHINTAN PHARMA CHEM is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of TATVA CHINTAN PHARMA CHEM ?
As on Mar 22,2023, the Intrinsic Value of TATVA CHINTAN PHARMA CHEM is Rs. 101.00 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 101.00
Fair Value [Median EV / Sales Model] : Rs. 76.17
Fair Value [Median Price / Sales Model] : Rs. 1,817.83
Estimated Median Fair Value of TATVA CHINTAN PHARMA CHEM : Rs. 101.00
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is TATVA CHINTAN PHARMA CHEM trading at a Premium or Discount?
As on Mar 22,2023, TATVA CHINTAN PHARMA CHEM is trading at a Premium of 1608% based on the estimates of Median Intrinsic Value!PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs GUJARAT FLUOROCHEMICALS LTD
DEEPAK NITRITE LTD vs TATA CHEMICALS LTD vs ATUL LTD
